SEC Form 4 · accession 0001645627-17-000059
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
May 11, 2017
Accepted (ET)
May 15, 2017 · 3:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 11, 2017 | P | 1,000 | $0.073 | A | 20,686,949 | D | |
| Common Stock | May 11, 2017 | P | 500 | $0.073 | A | 20,687,449 | D | |
| Common Stock | May 11, 2017 | P | 500 | $0.074 | A | 20,687,949 | D | |
| Common Stock | May 11, 2017 | P | 1,000 | $0.0739 | A | 20,688,949 | D | |
| Common Stock | May 11, 2017 | P | 1,000 | $0.066 | A | 20,689,949 | D | |
| Common Stock | May 11, 2017 | P | 1,000 | $0.067 | A | 20,690,949 | D | |
| Common Stock | May 11, 2017 | P | 1,000 | $0.0671 | A | 20,691,949 | D | |
| Common Stock | May 11, 2017 | P | 1,000 | $0.0679 | A | 20,692,949 | D | |
| Common Stock | May 11, 2017 | P | 1,000 | $0.07 | A | 20,693,949 | D | |
| Common Stock | May 11, 2017 | P | 1,000 | $0.071 | A | 20,694,949 | D | |
| Common Stock | May 11, 2017 | P | 1,000 | $0.072 | A | 20,695,949 | D | |
| Common Stock | May 11, 2017 | P | 1,000 | $0.07 | A | 20,696,949 | D | |
| Common Stock | May 11, 2017 | P | 1,000 | $0.07 | A | 20,697,949 | D | |
| Common Stock | May 11, 2017 | P | 1,000 | $0.068 | A | 20,698,949 | D | |
| Common Stock | May 11, 2017 | P | 2,000 | $0.068 | A | 20,700,949 | D | |
| Common Stock | May 11, 2017 | P | 1,000 | $0.067 | A | 20,701,949 | D | |
| Common Stock | May 11, 2017 | P | 1,000 | $0.07 | A | 20,702,949 | D | |
| Common Stock | May 11, 2017 | P | 1,000 | $0.0699 | A | 20,703,949 | D | |
| Common Stock | May 11, 2017 | P | 1,000 | $0.0698 | A | 20,704,949 | D | |
| Common Stock | May 12, 2017 | P | 1,000 | $0.065 | A | 20,705,949 | D | |
| Common Stock | May 12, 2017 | P | 1,000 | $0.065 | A | 20,706,949 | D | |
| Common Stock | May 12, 2017 | P | 1,000 | $0.065 | A | 20,707,949 | D | |
| Common Stock | May 12, 2017 | P | 1,000 | $0.065 | A | 20,708,949 | D | |
| Common Stock | May 12, 2017 | P | 1,000 | $0.064 | A | 20,709,949 | D | |
| Common Stock | May 12, 2017 | P | 1,000 | $0.064 | A | 20,710,949 | D | |
| Common Stock | May 12, 2017 | P | 1,000 | $0.064 | A | 20,711,949 | D | |
| Common Stock | May 12, 2017 | P | 1,000 | $0.063 | A | 20,712,949 | D | |
| Common Stock | May 12, 2017 | P | 1,000 | $0.063 | A | 20,713,949 | D | |
| Common Stock | May 12, 2017 | P | 1,000 | $0.063 | A | 20,714,949 | D | |
| Common Stock | May 12, 2017 | P | 1,000 | $0.064 | A | 20,715,949 | D |
Table II — derivative securities
No Table II lines on this filing.